SCHEMBL1940987

SCHEMBL1940987

COc1ccc(S(=O)(=O)Nc2cccc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.61
TCF4 P15884 1/20 0.52
CTNNB1 P35222 1/20 0.52
EGFR P00533 4/20 0.51
TEK Q02763 3/20 0.51
ERBB2 P04626 2/20 0.51
ERBB3 P21860 2/20 0.51
ERBB4 Q15303 2/20 0.51
EIF2AK3 Q9NZJ5 1/20 0.48
NTRK1 P04629 5/20 0.48
NTRK2 Q16620 3/20 0.48
KCNH2 Q12809 3/20 0.48
NTRK3 Q16288 2/20 0.48
RET P07949 1/20 0.47
PDPK1 O15530 1/20 0.46
CYP19A1 P11511 1/20 0.46
KDR P35968 3/20 0.44
FGFR1 P11362 2/20 0.44
ALDH1A1 P00352 2/20 0.44
GAA P10253 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1939477 0.91 PDGFRB (0.64) PDGFRBEGFRTEKERBB2ERBB3
SCHEMBL1939958 0.91 PDGFRB (0.64) PDGFRBTCF4CTNNB1EGFRTEK
SCHEMBL1940727 0.91 PDGFRB (0.66) PDGFRBEGFRTEKERBB2ERBB3
SCHEMBL1939766 0.90 PDGFRB (0.58) PDGFRBTCF4CTNNB1EGFRTEK
SCHEMBL1942165 0.90 PDGFRB (0.59) PDGFRBEGFRTEKERBB2ERBB3
SCHEMBL1941211 0.90 EIF2AK3 (0.58) PDGFRBTCF4CTNNB1EGFRTEK
SCHEMBL1940398 0.90 PDGFRB (0.63) PDGFRBEGFRTEKERBB2ERBB3
SCHEMBL1939560 0.90 PDGFRB (0.63) PDGFRBEGFRTEKERBB2ERBB3
SCHEMBL1941317 0.90 PDGFRB (0.65) PDGFRBEGFRTEKERBB2ERBB3
SCHEMBL1940035 0.90 PDGFRB (0.75) PDGFRBEGFRTEKERBB2ERBB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578751-B1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PROD INC (US) 2011-06-15 EP disclosed
US-7271262-B2 Pyrrolopyrimidine derivatives PFIZER INC (US) 2007-09-18 US disclosed
EP-1578751-A1 PYRROLOPYRIMIDINE DERIVATIVES Pfizer Products Inc. (US) 2005-09-28 EP disclosed
US-20050037999-A1 Pyrrolopyrimidine derivatives PFIZER INC 2005-02-17 US disclosed
WO-2004056830-A1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PRODUCTS INC. (US) 2004-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050037999-A1 Pyrrolopyrimidine derivatives CCNA1, CCNT1, TP53 PDGFRB 2465/4885TCF4 2809/4885CTNNB1 3403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.